Separation Systems for Commercial Biotechnology Market

Separation Systems for Commercial Biotechnology Market contains market size and forecasts of Separation Systems for Commercial Biotechnology in global, including the following market information:

Global Separation Systems for Commercial Biotechnology Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Separation Systems for Commercial Biotechnology Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Separation Systems for Commercial Biotechnology companies in 2021 (%)

The global Separation Systems for Commercial Biotechnology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Microarray Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Separation Systems for Commercial Biotechnology include Thermo Fisher Scientific, GE Healthcare, Agilent Technologies;Shimadzu Corporation, bioM?rieux SA, Bio-Rad Laboratories, Inc., Hitachi Koki, Merck &, Inc., QIAGEN and WATERS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Separation Systems for Commercial Biotechnology manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Separation Systems for Commercial Biotechnology Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Separation Systems for Commercial Biotechnology Market Segment Percentages, by Type, 2021 (%)

Microarray

Lab-on-a-chip

Biochip

Magnetic separation

Chromatography

Flow cytometry

Membrane filtration

Electrophoresis

Centrifugation

Others

Global Separation Systems for Commercial Biotechnology Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Separation Systems for Commercial Biotechnology Market Segment Percentages, by Application, 2021 (%)

Pharmaceutical

Food & Cosmetics

Agriculture

Others

Global Separation Systems for Commercial Biotechnology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Separation Systems for Commercial Biotechnology Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Separation Systems for Commercial Biotechnology revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Separation Systems for Commercial Biotechnology revenues share in global market, 2021 (%)

Key companies Separation Systems for Commercial Biotechnology sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Separation Systems for Commercial Biotechnology sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Thermo Fisher Scientific

GE Healthcare

Agilent Technologies;Shimadzu Corporation

bioM?rieux SA

Bio-Rad Laboratories, Inc.

Hitachi Koki

Merck &, Inc.

QIAGEN

WATERS

Sartorius

PerkinElmer, Inc.

Danaher

Miltenyi Biotec

BD